WESCAP Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,306
Closed -$282K 108
2025
Q4
$282K Hold
11,306
0.06% 100
2025
Q3
$288K Hold
11,306
0.06% 95
2025
Q2
$274K Hold
11,306
0.06% 94
2025
Q1
$286K Sell
11,306
-1,969
-15% -$51.5K 0.07% 91
2024
Q4
$352K Buy
13,275
+3,000
+29% +$81.4K 0.09% 86
2024
Q3
$297K Sell
10,275
-263
-2% -$7.67K 0.07% 84
2024
Q2
$295K Sell
10,538
-186
-2% -$5.12K 0.08% 85
2024
Q1
$298K Buy
10,724
+556
+5% +$15.4K 0.09% 84
2023
Q4
$293K Sell
10,168
-14,601
-59% -$441K 0.09% 82
2023
Q3
$822K Sell
24,769
-4,133
-14% -$146K 0.29% 56
2023
Q2
$1.06M Sell
28,902
-1,614
-5% -$62.8K 0.37% 51
2023
Q1
$1.25M Sell
30,516
-3,242
-10% -$140K 0.44% 44
2022
Q4
$1.73M Sell
33,758
-311
-0.9% -$14.9K 0.61% 40
2022
Q3
$1.49M Sell
34,069
-495
-1% -$24.1K 0.57% 41
2022
Q2
$1.81M Sell
34,564
-6,012
-15% -$306K 0.62% 37
2022
Q1
$2.1M Sell
40,576
-634
-2% -$32.9K 0.59% 39
2021
Q4
$2.43M Sell
41,210
-1,041
-2% -$51.6K 0.67% 37
2021
Q3
$1.82M Sell
42,251
-1,462
-3% -$64.8K 0.53% 40
2021
Q2
$1.59M Buy
43,713
+2,715
+7% +$106K 0.46% 46
2021
Q1
$1.49M Buy
+40,998
New +$1.46M 0.41% 46

Other funds holding PFE

WESCAP Management Group's PFE Position: Q1 2026 in Review

WESCAP Management Group sold out of Pfizer (PFE) in Q1 2026, closing a stake of 11,306 shares — an estimated $282K sold.

WESCAP Management Group first reported a position in PFE in Q1 2021 and held it in 20 quarters. The position peaked at $2.43M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • WESCAP Management Group reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • WESCAP Management Group sold 11,306 Pfizer shares in Q1 2026, an estimated $282K.
  • WESCAP Management Group first reported a position in Pfizer in Q1 2021 and held it in 20 quarters.
  • WESCAP Management Group's Pfizer position peaked at $2.43M in Q4 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on WESCAP Management Group's 13F filing for Q1 2026, filed 12 May 2026.